Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.76−0.23 (-7.69%)
Close on Nov 17, 2026Market cap $113.34MP/E –Yield –
Scienture cash
Cash and short-term investments held at the end of each period.
Scienture's cash was $8.19M at Jun 30, 2026. For fiscal 2025 it was $6.66M, up 2062.3% from the year before. Over ten years it grew 55.9% a year on average. The highest annual figure on record is $6.66M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.66M | +2062.3% |
| FY2024 | Dec 31, 2024 | $308.10K | +98019.7% |
| FY2023 | Dec 31, 2023 | $314 | -100.0% |
| FY2022 | Dec 31, 2022 | $1.09M | -64.9% |
| FY2021 | Dec 31, 2021 | $3.12M | -47.2% |
| FY2020 | Dec 31, 2020 | $5.92M | +106.1% |
| FY2019 | Dec 31, 2019 | $2.87M | +230.2% |
| FY2018 | Dec 31, 2018 | $869.56K | +372.8% |
| FY2017 | Dec 31, 2017 | $183.91K | +1152.9% |
| FY2016 | Dec 31, 2016 | $14.68K | -81.4% |
| FY2015 | Dec 31, 2015 | $78.71K | -88.7% |
| FY2014 | Dec 31, 2014 | $695.82K | +725.2% |
| FY2013 | Dec 31, 2013 | $84.32K | +2396.1% |
| FY2012 | Dec 31, 2012 | $3.38K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.19M | +53100.8% |
| Q1 FY2026 | Mar 31, 2026 | $3.54M | +72.8% |
| Q4 FY2025 | Dec 31, 2025 | $6.66M | +2062.3% |
| Q3 FY2025 | Sep 30, 2025 | $355.69K | -38.6% |
| Q2 FY2025 | Jun 30, 2025 | $15.39K | -99.8% |
| Q1 FY2025 | Mar 31, 2025 | $2.05M | -41.4% |
| Q4 FY2024 | Dec 31, 2024 | $308.10K | +98019.7% |
| Q3 FY2024 | Sep 30, 2024 | $579.10K | +1601.7% |
| Q2 FY2024 | Jun 30, 2024 | $7.72M | +935.5% |
| Q1 FY2024 | Mar 31, 2024 | $3.50M | +193.0% |
| Q4 FY2023 | Dec 31, 2023 | $314 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $34.03K | -89.4% |
| Q2 FY2023 | Jun 30, 2023 | $745.56K | -22.5% |
| Q1 FY2023 | Mar 31, 2023 | $1.19M | -36.2% |
| Q4 FY2022 | Dec 31, 2022 | $1.09M | -64.9% |
| Q3 FY2022 | Sep 30, 2022 | $321.72K | -91.0% |
| Q2 FY2022 | Jun 30, 2022 | $962.23K | -78.7% |
| Q1 FY2022 | Mar 31, 2022 | $1.87M | -64.1% |
| Q4 FY2021 | Dec 31, 2021 | $3.12M | -47.2% |
| Q3 FY2021 | Sep 30, 2021 | $3.57M | -46.3% |
| Q2 FY2021 | Jun 30, 2021 | $4.52M | +8.9% |
| Q1 FY2021 | Mar 31, 2021 | $5.21M | -32.4% |
| Q4 FY2020 | Dec 31, 2020 | $5.92M | +106.1% |
| Q3 FY2020 | Sep 30, 2020 | $6.65M | +97.9% |
| Q2 FY2020 | Jun 30, 2020 | $4.15M | +668.7% |
| Q1 FY2020 | Mar 31, 2020 | $7.70M | +1342.4% |
| Q4 FY2019 | Dec 31, 2019 | $2.87M | +230.2% |
| Q3 FY2019 | Sep 30, 2019 | $3.36M | +466.7% |
| Q2 FY2019 | Jun 30, 2019 | $540.03K | +159.7% |
| Q1 FY2019 | Mar 31, 2019 | $533.93K | +181.3% |
| Q4 FY2018 | Dec 31, 2018 | $869.56K | +372.8% |
| Q3 FY2018 | Sep 30, 2018 | $592.77K | +242.0% |
| Q2 FY2018 | Jun 30, 2018 | $207.91K | +101.5% |
| Q1 FY2018 | Mar 31, 2018 | $189.84K | +11.7% |
| Q4 FY2017 | Dec 31, 2017 | $183.91K | +1152.9% |
| Q3 FY2017 | Sep 30, 2017 | $173.33K | +94.6% |
| Q2 FY2017 | Jun 30, 2017 | $103.20K | – |
| Q1 FY2017 | Mar 31, 2017 | $170.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $14.68K | – |
| Q3 FY2016 | Sep 30, 2016 | $89.06K | – |
See a number that looks wrong?